Estrogen Receptor (ER) Antibody (Immunohistochemistry)

Estrogen Receptor (ER) Antibody (Immunohistochemistry)

The Estrogen Receptor (ER) Antibody is a key immunohistochemical marker used in the diagnosis and prognosis of breast cancer.
The ER protein is a nuclear estrogen receptor that regulates gene transcription in response to estrogen binding, influencing cell growth and differentiation.
ER positivity in breast tumors indicates a higher likelihood of response to anti-estrogen therapy, such as Tamoxifen.

In IHC staining, ER typically shows brown nuclear staining in positive epithelial cells, making it an essential marker for breast, ovarian, and endometrial tumors.

🔬 Features and Benefits Estrogen Receptor (ER) Antibody

• Essential marker for hormone receptor–positive breast cancers

• Distinct brown nuclear staining pattern

• Predictive value for anti-estrogen therapy (Tamoxifen)

• Applicable for FFPE samples with DAB detection systems

• Excellent stability: 18-month shelf life at 2–8 °C

💡 Diagnostic Applications

• Detection of ER-positive breast carcinomas

• Evaluation of hormone therapy responsiveness

• Differentiation of breast, ovarian, and endometrial tumors

• Research on estrogen receptor signaling and tumor biology

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of Talent Biomedical in Iran, supplies premium-quality immunohistochemistry antibodies, including ER.
With a strong commitment to diagnostic accuracy, scientific excellence, and international quality standards, Fardad Azma Rad provides reliable solutions for pathology and molecular laboratories across Iran.

“Download Brochure”